Updated On: 15 October, 2023 12:49 PM IST | San Francisco | IANS
The Peanut Sublingual Immunotherapy (Peanut SLIT) is safe in peanut-allergic toddlers, with a greater likelihood of desensitisation and remission the earlier the treatment began

Image for representational purposes only. Photo Courtesy: iStock
A tiny bit of protein therapy under the tongue could be a safe and effective approach in treating peanut-allergic children ranging from 1 to 4 years of age, a new study has shown.
According to the study published in the Journal of Allergy and Clinical Immunology, the Peanut Sublingual Immunotherapy (Peanut SLIT) is safe in peanut-allergic toddlers, with a greater likelihood of desensitisation and remission the earlier the treatment began.